Jak2V617F driven myeloproliferative neoplasm occurs independently of interleukin-3 receptor beta common signaling

• Therese Vu,
• Rebecca Austin,
• Catherine Paine Kuhn,
• Claudia Bruedigam,
• Axia Song,
• Solene Guignes,
• Sebastien Jacquelin,
• Hayley S. Ramshaw,
• Geoffrey R. Hill,
• Angel F. Lopez,
• Steven W. Lane

Affiliations

Therese Vu

Division of Immunology, QIMR Berghofer Medical Research Institute, Brisbane;School of Medicine, University of Queensland

Rebecca Austin

Division of Immunology, QIMR Berghofer Medical Research Institute, Brisbane;School of Medicine, University of Queensland

Catherine Paine Kuhn

Division of Immunology, QIMR Berghofer Medical Research Institute, Brisbane

Claudia Bruedigam

Division of Immunology, QIMR Berghofer Medical Research Institute, Brisbane

Axia Song

Division of Immunology, QIMR Berghofer Medical Research Institute, Brisbane

Solene Guignes

Division of Immunology, QIMR Berghofer Medical Research Institute, Brisbane

Sebastien Jacquelin

Division of Immunology, QIMR Berghofer Medical Research Institute, Brisbane

Hayley S. Ramshaw

Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide

Geoffrey R. Hill

Division of Immunology, QIMR Berghofer Medical Research Institute, Brisbane;Cancer Care Services, Royal Brisbane and Women’s Hospital, Brisbane, Australia

Angel F. Lopez

Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide

Steven W. Lane

Division of Immunology, QIMR Berghofer Medical Research Institute, Brisbane;School of Medicine, University of Queensland;Cancer Care Services, Royal Brisbane and Women’s Hospital, Brisbane, Australia